ANKRD44 and non-small cell lung carcinoma: In this study, we construct a prognosis risk model to predict the overall survival (OS) outcomes of NSCLC patients based on the expression of five hub ANKRD genes (ANKRD29, ANKRD34B, ANKRD40CL, ANKRD44 and ANKRD66).